“A Chronopharmacological Study Related to Doxorubicin Based Bone Marrow Suppression”, Int. J. Pharma Life Sci., vol. 2, no. 5, pp. 197–201, Jan. 2014, doi: 10.3329/ijpls.v2i5.17627.